tiprankstipranks
Reach plc (GB:RCH)
LSE:RCH
Holding GB:RCH?
Track your performance easily

Reach plc (RCH) Income Statement

31 Followers

Reach plc Income Statement

Last quarter (Q4 2022), Reach plc's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Reach plc's net income was £―. See Reach plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
-£ 601.40M£ 615.80M£ 600.20M£ 702.50M£ 723.90M
Cost of Revenue
-£ 188.40M£ 329.40M£ 303.20M£ 370.70M£ 377.40M
Gross Profit
-£ 413.00M£ 286.40M£ 297.00M£ 331.80M£ 346.50M
Operating Expense
-£ 293.00M£ 187.10M£ 199.90M£ 194.10M£ 234.30M
Operating Income
-£ 120.00M£ 99.30M£ 97.10M£ 137.70M£ 112.20M
Net Non Operating Interest Income Expense
-£ -2.80M£ 6.00M£ 7.20M£ 10.80M£ 12.30M
Other Income Expense
-£ 35.70M£ -1.60M£ -1.40M£ -7.40M£ -800.00K
Pretax Income
-£ 66.20M£ 73.30M£ 400.00K£ 120.90M£ -119.90M
Tax Provision
-£ 13.90M£ 70.40M£ 27.10M£ 26.60M£ -300.00K
Earnings From Equity Interest Net Of Tax
-£ -33.40M£ 1.60M£ 1.40M£ 7.40M£ 800.00K
Net Income Common Stockholders
-£ 52.30M£ 2.90M£ -26.70M£ 94.30M£ -119.60M
Basic EPS
-£ 0.17£ 0.01£ -0.09£ 0.29£ -0.37
Diluted EPS
-£ 0.17£ 0.01£ -0.09£ 0.29£ -0.37
Basic Average Shares
-£ 312.15M£ 310.28M£ 309.43M£ 322.01M£ 316.95M
Diluted Average Shares
-£ 316.98M£ 319.25M£ 316.25M£ 325.77M£ 318.65M
Dividend Per Share
-£ 0.07£ 0.07£ 4.26£ 0.06£ 0.06
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-£ 481.40M£ -516.50M£ -503.10M£ -564.80M£ -611.70M
Net Income From Continuing And Discontinued Operation
-£ 52.30M£ 2.90M£ -26.70M£ 94.30M£ -119.60M
Normalized Income
-£ 69.62M£ 80.97M£ 324.00K£ 97.93M£ -120.20M
Interest Expense
------
EBIT
-£ 69.10M£ 76.00M£ 3.00M£ 123.80M£ -132.20M
EBITDA
-£ 89.30M£ 76.00M£ 30.40M£ 123.80M-
Currency in GBP

Reach plc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis